Core Points - Main Street Financial Services Corp. held its 2025 Annual Meeting of Stockholders on May 8, 2025, where key proposals were voted on and approved [1][3] - The election of three directors was successful, with nominees David L. Lehman, Debra A. Marthey, and Lance J. Ciroli receiving majority "FOR" votes [2] - The 2025 Equity Incentive Plan was approved by stockholders, with 3,927,358 votes in favor, 418,074 against, and 70,993 abstentions [2] - The appointment of Forvis Mazars, LLP as the independent registered public accounting firm for the year ending December 31, 2025, was ratified with 5,657,798 votes in favor [3] - Executive Chair Mark R. Witmer expressed gratitude for shareholder support and highlighted the company's commitment to long-term growth and stability following a pivotal year marked by a successful merger [3]

May 12, 2025 45700 Northport Loop East Fremont, California 94538 Dear [Investor], I am writing to you as one of our largest SunPower shareholders [Nasdaq: SPWR] to ask for your proxy vote in our 'virtual' annual meeting of stockholders at 11:00 a.m. Pacific Time on Thursday, May 29, 2025. While annual meetings have shrunk in size, this particular virtual meeting is critical to the new SunPower and its shareholders. We need shareholder approval for three proposals. The first two proposals are both non-contro ...

Table of Contents As filed with the U.S. Securities and Exchange Commission on November 9, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Diebold Nixdorf, Incorporated (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 3578 34-0183970 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identifica ...

As filed with the Securities and Exchange Commission on July 19, 2023 Registration No. 333-269188 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Amendment No. 4 to Form S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHROMOCELL THERAPEUTICS CORPORATION (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2836 86-3335449 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 4400 ...